Vir Biotechnology Inc. (VIR)
NASDAQ: VIR
· Real-Time Price · USD
5.27
0.09 (1.74%)
At close: Sep 22, 2025, 3:59 PM
5.34
1.33%
After-hours: Sep 22, 2025, 07:29 PM EDT
1.74% (1D)
| Bid | 5.24 |
| Market Cap | 732.09M |
| Revenue (ttm) | 16.67M |
| Net Income (ttm) | -550.23M |
| EPS (ttm) | -4.01 |
| PE Ratio (ttm) | -1.31 |
| Forward PE | -1.84 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 5.31 |
| Volume | 859,817 |
| Avg. Volume (20D) | 1,262,703 |
| Open | 5.18 |
| Previous Close | 5.18 |
| Day's Range | 5.06 - 5.48 |
| 52-Week Range | 4.16 - 14.45 |
| Beta | 1.28 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for VIR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsVir Biotechnology Inc. is scheduled to release its earnings on
Oct 30, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+17.79%
Vir Biotechnology shares are trading higher after ...
Unlock content with
Pro Subscription
1 month ago
-0.59%
Vir Biotechnology shares are trading lower after the company reported worse-than-expected Q2 financial results.
3 weeks ago · https://thefly.com
BofA upgrades Vir Biotechnology to Buy on underappreciated HDV opportunityAs previously reported, BofA analyst Alec Stranahan upgraded Vir Biotechnology to Buy from Neutral with a price target of $14, up from $12, arguing that the market is underestimating the potential for...
